Related Experiment Video
Updated: Dec 30, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.8K
Atrial fibrillation: an update on management
Craig J McCallum1, Deep Chandh Raja1, Rajeev Kumar Pathak1
1Cardiac Electrophysiology Unit, Department of Cardiology, Canberra Hospital and Health Services, Australian National University.
Australian Prescriber
|January 16, 2020
Summary
Opportunistic screening for atrial fibrillation (AF) in general practice is recommended due to its association with stroke and heart dysfunction. Management focuses on risk factor modification, rate control, and anticoagulation using the CHA2DS2-VASc score.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Atrial fibrillation (AF) significantly increases stroke and left ventricular dysfunction risk.
- AF is linked to reduced quality of life.
- Silent AF may be underdiagnosed, highlighting the need for screening.
Purpose of the Study:
- To emphasize the importance of opportunistic screening for atrial fibrillation in primary care settings.
- To outline current management strategies for atrial fibrillation.
- To discuss the role of risk stratification and therapeutic interventions.
Main Methods:
- Review of current guidelines and evidence for atrial fibrillation management.
- Assessment of risk factors and their modification.
- Evaluation of diagnostic tools like opportunistic screening.
- Discussion of therapeutic options including drug therapy and catheter ablation.
Main Results:
- Opportunistic screening in general practice is advised for early detection of atrial fibrillation.
- Risk factor modification is central to AF management.
- The revised CHA2DS2-VASc score aids in assessing anticoagulant therapy needs.
- Direct oral anticoagulants are preferred over warfarin where appropriate.
- Catheter ablation offers survival benefits for patients with left ventricular dysfunction and improves quality of life.
Conclusions:
- Early detection and comprehensive management of atrial fibrillation are crucial.
- Risk factor modification, appropriate anticoagulation, and consideration of catheter ablation are key components of care.
- Screening strategies can help mitigate the adverse outcomes associated with atrial fibrillation.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
342
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
342
01:26Mitral Stenosis III: Medical Management
194
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
194
01:25Aortic Regurgitation III: Medical Management
316
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
316
01:25Mitral Regurgitation III: Medical Management
217
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
217
01:29Venous Thrombosis III: Interprofessional Care
234
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
234
01:26Atherosclerosis III: Management
280
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
280